Handelsbanken Fonder
PFE icon

Handelsbanken Fonder’s Pfizer PFE Stock Holding History

Handelsbanken Fonder’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.3M Buy
2,462,431
+232,528
+10% +$6.08M 0.17% 97
2026
Q1 		$62.6M Sell
2,229,903
-136,287
-6% -$3.63M 0.21% 92
2025
Q4 		$58.9M Sell
2,366,190
-31,871
-1% -$804K 0.18% 102
2025
Q3 		$61.1M Sell
2,398,061
-44,533
-2% -$1.1M 0.19% 100
2025
Q2 		$59.2M Buy
2,442,594
+9,639
+0.4% +$225K 0.21% 99
2025
Q1 		$61.7M Buy
2,432,955
+15,509
+0.6% +$406K 0.25% 82
2024
Q4 		$64.1M Buy
2,417,446
+83,017
+4% +$2.25M 0.24% 82
2024
Q3 		$67.6M Buy
2,334,429
+53,531
+2% +$1.56M 0.27% 81
2024
Q2 		$63.8M Buy
2,280,898
+67,779
+3% +$1.87M 0.28% 70
2024
Q1 		$61.4M Sell
2,213,119
-415,031
-16% -$11.5M 0.26% 82
2023
Q4 		$75.7M Sell
2,628,150
-205,389
-7% -$6.21M 0.37% 53
2023
Q3 		$94M Sell
2,833,539
-56,070
-2% -$1.98M 0.53% 35
2023
Q2 		$106M Buy
2,889,609
+513,760
+22% +$20M 0.57% 31
2023
Q1 		$96.9M Sell
2,375,849
-136,805
-5% -$5.91M 0.56% 33
2022
Q4 		$129M Buy
2,512,654
+41,835
+2% +$2.01M 0.81% 19
2022
Q3 		$108M Buy
2,470,819
+62,900
+3% +$3.06M 0.72% 23
2022
Q2 		$126M Buy
2,407,919
+260,481
+12% +$13.3M 0.82% 19
2022
Q1 		$111M Sell
2,147,438
-174,531
-8% -$9.06M 0.62% 27
2021
Q4 		$137M Buy
2,321,969
+887,702
+62% +$44M 0.68% 24
2021
Q3 		$61.7M Sell
1,434,267
-11,038
-0.8% -$489K 0.32% 63
2021
Q2 		$56.6M Sell
1,445,305
-454
-0% -$17.7K 0.3% 73
2021
Q1 		$52.4M Buy
1,445,759
+37,352
+3% +$1.33M 0.3% 78
2020
Q4 		$51.8M Sell
1,408,407
-86,427
-6% -$3.17M 0.32% 75
2020
Q3 		$52M Buy
1,494,834
+27,994
+2% +$981K 0.38% 57
2020
Q2 		$45.5M Buy
+1,466,840
New +$49.8M 0.38% 58
2018
Q2 		– Sell
-64,958
Closed -$2.19M – 220
2018
Q1 		$2.19M Hold
64,958
– – 0.04% 169
2017
Q4 		$2.23M Sell
64,958
-31,620
-33% -$1.08M 0.05% 156
2017
Q3 		$3.27M Sell
96,578
-94,860
-50% -$3.05M 0.08% 149
2017
Q2 		$6.1M Sell
191,438
-21,080
-10% -$665K 0.16% 119
2017
Q1 		$6.9M Sell
212,518
-52,700
-20% -$1.66M 0.19% 100
2016
Q4 		$8.17M Sell
265,218
-11,594
-4% -$354K 0.25% 99
2016
Q3 		$8.89M Sell
276,812
-132,738
-32% -$4.44M 0.26% 101
2016
Q2 		$13.7M Buy
409,550
+60,078
+17% +$1.92M 0.56% 66
2016
Q1 		$9.83M Sell
349,472
-773,703
-69% -$22.1M 0.42% 74
2015
Q4 		$34.4M Buy
+1,123,175
New +$35.3M 0.66% 36

Other funds holding PFE

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
KC
Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Handelsbanken Fonder's PFE Position: Q2 2026 in Review

Handelsbanken Fonder increased its Pfizer (PFE) stake by 10% in Q2 2026, buying an estimated $6.08M and bringing the position to 2,462,431 shares worth $59.3M. The position accounts for 0.17% of the portfolio, ranked #97.

Handelsbanken Fonder first reported a position in PFE in Q4 2015 and has held it in 35 quarters since. The position peaked at $137M in Q4 2021. 483 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Handelsbanken Fonder held 2,462,431 shares of Pfizer worth $59.3M as of Q2 2026.
  • Handelsbanken Fonder bought 232,528 Pfizer shares in Q2 2026, an estimated $6.08M.
  • Pfizer made up 0.17% of Handelsbanken Fonder's portfolio in Q2 2026, its #97 holding.
  • Handelsbanken Fonder first reported a position in Pfizer in Q4 2015 and has held it in 35 quarters since.
  • Handelsbanken Fonder's Pfizer position peaked at $137M in Q4 2021.
  • 483 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.